ArticleCancer research2016

FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.

Elie Traer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.